Skip to content

Released Nov 13, 2014, after the close

10-Q filed Nov 13, 2014, 44 days after period end · 0001144204-14-067701

Q3 2014 · 10-Q
Revenue$5.13M−13.8% vs Q3 2013+185.5% vs Q2 2014
Net Income-$3.22MN/M vs Q3 2013N/M vs Q2 2014
EPS Diluted-$0.18N/M vs Q3 2013N/M vs Q2 2014
Gross Profit$3,510,000−8.0%
Operating Income-$3,215,000N/M
Operating Cash Flowderived-$2,442,000N/M
Free Cash Flowderived-$2,486,000N/M
Margins · derived
Gross margin68.4%+4.3 pt vs Q3 2013
Operating margin-62.7%−83.5 pt vs Q3 2013
Net margin-62.7%−83.5 pt vs Q3 2013

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2014Q3 2013Q3 2012Q3 2011
Revenue$5.13M$5.95M$5.42M$5.08M
Net Income-$3.22M$1.24M$1.07M$1.11M
EPS Diluted-$0.18$0.08$0.07$0.07

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR